The Food and Drug Administration has authorized Pfizer and Moderna COVID-19 vaccine booster shots for all American adults. The decision was based on Phase III trials that found boosters were safe and extremely effective against the virus. (CNN)

The drug pricing plan proposed by Democrats cleared a hurdle Friday when the Build Back Better bill passed the House of Representatives. The pricing proposal could save the federal government $300 billion, though the bill has yet to pass the Senate. (STAT)

The FDA has given BioNTech fast-track designation for its new skin cancer therapy based on RNA technology. The therapy is an infusion that spurs the body to produce proteins and start an immune response against cancer cells. (Reuters)

The FDA has agreed on an accelerated approval process for Bimarin’s Voxzogo injection, the first treatment to tackle the underlying causes of dwarfism. The injection hinders the gene responsible for dwarfism and boosts bone growth in kids. (Endpoints News)

With the exception of vaccination, wearing masks remains the most effective tool to prevent the spread of COVID-19, according to a new global analysis. Mask-wearing, the analysis found, decreased the incidence of COVID-19 by 53%. (Business Insider)